Effects of saffron and its active constituent crocin on cancer management: A narrative review - PubMed
Effects of saffron and its active constituent crocin on cancer management: A narrative review
Chong-Zhi Wang et al. Longhua Chin Med. 2022.
Abstract
Background and objective: Cancer is a major public health problem in the world, and it dramatically affects the life expectancy of patients and their quality of life. Natural products from botanicals could be beneficial in the prevention or treatment of a variety of cancers. Saffron (the extract of Crocus sativus) includes its major constituent, crocin, have been used as a folk medicine for a long time, and they have shown obvious cancer chemoprevention potential. The objectives of this review are to present the progress of research on the effects of saffron and crocin in cancer management and the underlying mechanisms of action.
Methods: We searched publications in the English language, published between January 1, 1980 and September 30, 2022, of saffron and crocin on cancer through several search engines, i.e., PubMed, SciFinder and Web of Science.
Key content and findings: In this article, we first summarize the phytochemical studies of this botanical. Then, we present the anticancer effects of saffron and crocin on different human cancer cells. Saffron and crocin showed obvious antiproliferative effects on human cancer cell lines, including colorectal cancer, breast cancer, lung cancer, prostate cancer, cervical cancer, leukemia, glioblastoma and rhabdomyosarcoma. Finally, the anticancer-related mechanisms of action are summarized, including cell cycle arrest at G0/G1 or G2/M phases, induction of caspase-dependent apoptosis, signaling pathway-linked tumor metabolism regulation, and adaptive immunity regulated inflammation of host immune responses.
Conclusions: Previous studies related to saffron and crocin in cancer management have been reviewed and reported results have been analyzed. Clinical data suggest that saffron and crocin have beneficial effects to improve quality of life in cancer patients. Thus, saffron and crocin can be considered promising candidates for future clinical cancer studies.
Keywords: Crocus sativus and saffron; anticancer; crocin; immune response; signaling pathway.
Conflict of interest statement
All authors have completed the ICMJE uniform disclosure form (available at https://lcm.amegroups.com/article/view/10.21037/lcm-21-72/coif). The series “Multifunctional Saffron” was commissioned by the editorial office without any funding or sponsorship. CZW serves as an unpaid editorial board member of Longhua Chinese Medicine from November 2021 to October 2023. YS serves as an unpaid Associate Editor-in-Chief of Longhua Chinese Medicine from September 2022 to August 2024 and served as the unpaid Guest Editor of the series. The authors have no other conflicts of interest to declare.
Similar articles
-
Role of saffron and its constituents on cancer chemoprevention.
Zhang Z, Wang CZ, Wen XD, Shoyama Y, Yuan CS. Zhang Z, et al. Pharm Biol. 2013 Jul;51(7):920-4. doi: 10.3109/13880209.2013.771190. Epub 2013 Apr 9. Pharm Biol. 2013. PMID: 23570520 Free PMC article. Review.
-
Crocetin and Crocin from Saffron in Cancer Chemotherapy and Chemoprevention.
Colapietro A, Mancini A, D'Alessandro AM, Festuccia C. Colapietro A, et al. Anticancer Agents Med Chem. 2019;19(1):38-47. doi: 10.2174/1871520619666181231112453. Anticancer Agents Med Chem. 2019. PMID: 30599111 Review.
-
D'Alessandro AM, Mancini A, Lizzi AR, De Simone A, Marroccella CE, Gravina GL, Tatone C, Festuccia C. D'Alessandro AM, et al. Nutr Cancer. 2013;65(6):930-42. doi: 10.1080/01635581.2013.767368. Nutr Cancer. 2013. PMID: 23909737
-
[In vitro evaluation of the chemopreventive potential of saffron].
Abdullaev Jafarova F, Caballero-Ortega H, Riverón-Negrete L, Pereda-Miranda R, Rivera-Luna R, Manuel Hernández J, Pérez-López I, Espinosa-Aguirre JJ. Abdullaev Jafarova F, et al. Rev Invest Clin. 2002 Sep-Oct;54(5):430-6. Rev Invest Clin. 2002. PMID: 12587418 Spanish.
-
Safakhah HA, Taghavi T, Rashidy-Pour A, Vafaei AA, Sokhanvar M, Mohebbi N, Rezaei-Tavirani M. Safakhah HA, et al. Iran J Pharm Res. 2016 Winter;15(1):253-61. Iran J Pharm Res. 2016. PMID: 27610166 Free PMC article.
Cited by
-
Talib WH, Abed I, Raad D, Alomari RK, Jamal A, Jabbar R, Alhasan EOA, Alshaeri HK, Alasmari MM, Law D. Talib WH, et al. Foods. 2024 Aug 26;13(17):2687. doi: 10.3390/foods13172687. Foods. 2024. PMID: 39272454 Free PMC article. Review.
-
Al Alabdullah MAA, Goodarzi MT, Homayouni Tabrizi M. Al Alabdullah MAA, et al. Sci Rep. 2024 Jun 26;14(1):14769. doi: 10.1038/s41598-024-65881-w. Sci Rep. 2024. PMID: 38926533 Free PMC article.
-
A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer.
Dachani SR, Kaleem M, Mujtaba MA, Mahajan N, Ali SA, Almutairy AF, Mahmood D, Anwer MK, Ali MD, Kumar S. Dachani SR, et al. ACS Omega. 2024 Feb 22;9(9):10030-10048. doi: 10.1021/acsomega.3c09780. eCollection 2024 Mar 5. ACS Omega. 2024. PMID: 38463249 Free PMC article. Review.
-
Saffron as a Promising Therapy for Inflammatory Bowel Disease.
Rashid M, Rashid R, Saroya S, Deverapalli M, Brim H, Ashktorab H. Rashid M, et al. Nutrients. 2024 Jul 20;16(14):2353. doi: 10.3390/nu16142353. Nutrients. 2024. PMID: 39064796 Free PMC article. Review.
References
-
- Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin 2021;71:7–33. - PubMed
-
- Islami F, Siegel RL, Jemal A. The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment. Nat Rev Clin Oncol 2020;17:631–49. - PubMed
-
- Glynne-Jones R, Mathur P, Elton C, et al. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer. Best Pract Res Clin Gastroenterol 2007;21:1049–70. - PubMed
-
- Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod 2020;83:770–803. - PubMed
LinkOut - more resources
Full Text Sources